| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 25-Oct-08 | | Total Revenue | 4,747,528 | 4,354,224 | 5,380,025 | 4,634,063 | | Cost of Revenue | 3,534,302 | 3,273,346 | 4,160,712 | 3,425,494 | | | Gross Profit | 1,213,226 | 1,080,878 | 1,219,313 | 1,208,569 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 790,876 | 735,057 | 839,531 | 765,104 | | Non Recurring |
-
|
-
| (23,500) | (7,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 422,350 | 345,821 | 403,282 | 450,465 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 422,350 | 345,821 | 403,282 | 450,465 | | Interest Expense | 9,249 | 6,601 | 4,527 | 5,449 | | Income Before Tax | 413,101 | 339,220 | 398,755 | 445,016 | | Income Tax Expense | 151,540 | 130,006 | 148,059 | 174,898 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 261,561 | 209,214 | 250,696 | 270,118 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (34,269) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 261,561 | 209,214 | 250,696 | 235,849 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $261,561 | $209,214 | $250,696 | $235,849 |
|
0.15% Nasdaq 
Income Statement
